Petros Pharmaceuticals, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Petros Pharmaceuticals, Inc. annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q1 2020 to Q1 2023.
  • Petros Pharmaceuticals, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2023 was $142K.
  • Petros Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $536K, a 10% decline from 2022.
  • Petros Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $596K, a 41.3% increase from 2021.
  • Petros Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $422K, a 64.6% decline from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $142K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2021 $177K -$195K -52.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $372K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.